Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 28, 2010, Pages 12629-12633

  Walsh, Tom ^a   Lee, Ming K ^a   Casadei, Silvia ^a   Thornton, Anne M ^a   Stray, Sunday M ^a   Pennil, Christopher ^b   Nord, Alex S ^a   Mandell, Jessica B ^a   Swisher, Elizabeth M ^b   King, Mary Claire ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; Genetic testing; Genomics; Next generation sequencing

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENOMIC DNA;

ARTICLE; BASE PAIRING; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA HYBRIDIZATION; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; GENOMICS; HUMAN; NONSENSE MUTATION; OVARY CANCER; PRIORITY JOURNAL; TUMOR GENE;

BASE SEQUENCE; BRCA2 PROTEIN; FEMALE; FRAMESHIFT MUTATION; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; GENOME; HUMANS; MUTAGENESIS, INSERTIONAL; MUTATION; OVARIAN NEOPLASMS; RISK ASSESSMENT; SEQUENCE DELETION;

EID: 77955439715     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1007983107     Document Type: Article

References (33)

1. King MC, Marks JH, Mandell JB; New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643-646. (Pubitemid 37310920)
2. Seal S, et al.; Breast Cancer Susceptibility Collaboration (UK) (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38:1239-1241.
3. Rahman N, et al.; Breast Cancer Susceptibility Collaboration (UK) (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165-167.
4. Gonzalez KD, et al. (2009) Beyond Li Fraumeni syndrome: Clinical characteristics of families with p53 germline mutations. J Clin Oncol 27:1250-1256.
5. FitzGerald MG, et al. (1998) Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene 17:727-731.
6. Hearle N, et al. (2006) Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 12:3209-3215.
7. Schrader KA, et al. (2008) Hereditary diffuse gastric cancer: Association with lobular breast cancer. Fam Cancer 7:73-82.
8. Aarnio M, et al. (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214-218. (Pubitemid 29144749)
9. Frank TS, et al. (1998) Sequence analysis of BRCA1 and BRCA2: Correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16:2417-2425.
10. Aymé S, Matthijs G, Soini S; ESHG Working Party on Patenting and Licensing (2008) Patenting and licensing in genetic testing. Eur J Hum Genet 16(Suppl 1):S10-S19.
11. Matthijs G, Hodgson S (2008) The impact of patenting on DNA diagnostic practice. Clin Med 8:58-60. (Pubitemid 351251569)
12. Lifton RP (2010) Individual genomes on the horizon. N Engl J Med 362:1235-1236.
13. Goossens D, et al. (2009) Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat 30:472-476.
14. Daiger SP, et al. (2010) Targeted high-throughput DNA sequencing for gene discovery in retinitis pigmentosa. Adv Exp Med Biol 664:325-331.
15. Hoischen A, et al. (2010) Massively parallel sequencing of ataxia genes after array-based enrichment. Hum Mutat 31:494-499.
16. Chou LS, Liu CS, Boese B, Zhang X, Mao R (2010) DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: Neurofibromatosis type 1 gene as a model. Clin Chem 56:62-72.
17. Mamanova L, et al. (2010) Target-enrichment strategies for next-generation sequencing. Nat Methods 7:111-118.
18. Petitjean A, et al. (2007) Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: Lessons from recent developments in the IARC TP53 database. Hum Mutat 28:622-629.
19. Walsh T, et al. (2006) Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA 295:1379-1388.
20. Kesselheim AS, Mello MM (2010) Gene patenting: Is the pendulum swinging back? N Engl J Med 362:1855-1858.
21. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103-105. (Pubitemid 46209856)
22. Summerer D, et al. (2009) Microarray-based multicycle-enrichment of genomic subsets for targeted next-generation sequencing. Genome Res 19:1616-1621.
23. Schroeder C, Stutzmann F, Weber BH, Riess O, Bonin M (2010) High-throughput resequencing in the diagnosis of BRCA1/2 mutations using oligonucleotide resequencing microarrays. Breast Cancer Res Treat 122:287-297.
24. Morgan JE, et al. (2010) Genetic diagnosis of familial breast cancer using clonal sequencing. Hum Mutat 31:484-491.
25. Hogervorst FB, et al. (2003) Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res 63:1449-1453.
26. Euhus DM, et al. (2002) Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst 94:844-851.
27. Berry DA, et al. (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712.
28. Bryant HE, et al. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434:913-917.
29. Farmer H, et al. (2005) Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917-921.
30. Mattocks CJ, for the EuroGentest Validation Group. (2010) A standardized framework for the validation and verification of clinical molecular genetic tests. Eur J Hum Genet, in press.
31. Tewhey R, et al. (2009) Enrichment of sequencing targets from the human genome by solution hybridization. Genome Biol 10:R116.
32. Li H, Ruan J, Durbin R (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18:1851-1858.
33. Li C, Hung Wong W. (2001) Model-based analysis of oligonucleotide arrays: Model validation, design issues and standard error application. Genome Biol 2:0032.